Regdanvimab
Monoclonal antibody
Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion.
Nº Q105687595 ★★
Poco común · Saberes
Regdanvimab
Monoclonal antibody
Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion.
Último precio
—
Precio mínimo
—
Mediana 7 d
—
Ventas 30 d
0
Rango 30 d
—
En circulación
0
Cotización
mediana
mín – máx
ventas
Sin ventas en el periodo
Ver tabla
| Fecha | mediana | Mín | Máx | ventas |
|---|
Historial de ventas
- Última venta
- —
- Media 30 d
- —
- Mínimo 30 d
- —
- Máximo 30 d
- —
- Ventas 7 d
- 0
- Ventas 30 d
- 0
Aún no hay ventas.
Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19. The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion. The medicine is given by infusion (drip) into a vein. The most common side effects include infusion-related reactions, including allergic reactions and anaphylaxis. Regdanvimab was authorized for medical use in the European Union in November 2021.
Texto: Wikipedia en inglés, CC BY-SA 4.0. ·
Cartas cercanas
Bamlanivimab
Nº Q100391783 ★★
GS-441524
Metabolito derivado de remdesivir
Nº Q94518604 ★
Remdesivir
Compuesto químico
Nº Q28209496 ★★★
Molnupiravir
Compuesto químico
Nº Q96376832 ★★
nirmatrelvir
Compuesto químico
Nº Q106405348 ★★
SARS-CoV-2
Virus ARN monocatenario positivo de la familia Coronaviridae
Nº Q82069695 ★★★★